HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cesar Rodriguez Selected Research

Immunoglobulin G (IgG)

11/2023Incidence, timing, and management of infections in patients receiving teclistamab for the treatment of relapsed/refractory multiple myeloma in the MajesTEC-1 study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cesar Rodriguez Research Topics

Disease

21Multiple Myeloma
04/2024 - 09/2017
5Neoplasms (Cancer)
04/2024 - 09/2017
3Infections
12/2023 - 11/2023
2Neutropenia
11/2023 - 09/2017
2Graft vs Host Disease (Graft-Versus-Host Disease)
10/2020 - 01/2018
1Chromosome Aberrations (Chromosome Abnormalities)
04/2024
1Fever (Fevers)
11/2023
1Agammaglobulinemia (Hypogammaglobulinemia)
11/2023
1Cytokine Release Syndrome
01/2023
1Thrombosis (Thrombus)
11/2022
1Hematologic Neoplasms (Hematological Malignancy)
01/2021
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021
1Necrosis
10/2020
1Frailty
05/2019
1Paraproteinemias (Monoclonal Gammopathy)
01/2019
1Neoplasm Metastasis (Metastasis)
01/2019
1Melanoma (Melanoma, Malignant)
01/2019
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2019
1Hyperplasia
01/2019
1Breast Neoplasms (Breast Cancer)
08/2018
1Thrombocytopenia (Thrombopenia)
09/2017
1Disease Progression
09/2017
1Thyrotoxicosis
02/2008
1Graves Disease (Basedow Disease)
02/2008
1Nodular Goiter
02/2008
1Depressive Disorder (Melancholia)
05/2002

Drug/Important Bio-Agent (IBA)

10Lenalidomide (CC 5013)FDA Link
04/2024 - 09/2017
9daratumumabIBA
04/2024 - 01/2020
8Dexamethasone (Maxidex)FDA LinkGeneric
04/2024 - 01/2020
7Bortezomib (Velcade)FDA Link
04/2024 - 01/2020
5B-Cell Maturation AntigenIBA
12/2023 - 11/2022
5Bispecific AntibodiesIBA
12/2023 - 01/2023
4bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
12/2023 - 04/2022
2Intravenous Immunoglobulins (IVIG)FDA Link
12/2023 - 11/2023
2Chimeric Antigen ReceptorsIBA
01/2023 - 01/2023
1Adenosine Monophosphate (AMP)IBA
04/2024
1VaccinesIBA
12/2023
1Immunoglobulin G (IgG)IBA
11/2023
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
11/2023
1Immunoglobulins (Immunoglobulin)IBA
11/2023
1Proteins (Proteins, Gene)FDA Link
10/2023
1crisamicin AIBA
01/2023
1Immunoconjugates (Immunoconjugate)IBA
01/2023
1CytokinesIBA
01/2023
1vinyltriethoxysilane (VTES)IBA
11/2022
1CalciumIBA
10/2020
1Vitamin DFDA LinkGeneric
10/2020
1Gonadal HormonesIBA
10/2020
1Infliximab (Remicade)FDA Link
01/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2019
1Cysteine (L-Cysteine)FDA Link
01/2019
1Blood Proteins (Serum Proteins)IBA
01/2019
1AntioxidantsIBA
01/2019
1human ERBB2 proteinIBA
08/2018
1Ado-Trastuzumab EmtansineIBA
08/2018
1Thyroid HormonesIBA
02/2008
1Dihydrotachysterol (AT 10)IBA
05/2002

Therapy/Procedure

16Therapeutics
04/2024 - 09/2017
5Stem Cell Transplantation
10/2023 - 09/2017
3Cell Transplantation
01/2021 - 10/2020
2Transplantation
10/2023 - 01/2021
1Duration of Therapy
11/2023
1Salvage Therapy
01/2023
1Hematopoietic Stem Cell Mobilization
01/2023
1Aftercare (After-Treatment)
01/2023
1Biological Therapy
04/2022
1Precision Medicine
05/2021
1Drug Therapy (Chemotherapy)
10/2020
1Patient Transfer (Patient Dumping)
01/2018